(Bloomberg) -- Biovac, South Africa's state vaccine company, will manufacture the Hexaxim vaccine under license from Sanofi Pasteur, marking the first manufacture of vaccines in the country since the mid 1990s.
The vaccine protects against six common diseases affecting infants, the companies said in a statement on Thursday.
©2020 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
